Sequence Similarity Clusters for the Entities in PDB 4HWE

Entity #1 | Chains: H
Fab heavy chain protein, length: 227 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 47806
95 % 1 2 39738 Flexibility: Low
Max RMSD: 0.7, Avg RMSD: 0.7
PDBFlex
90 % 21 36 1224
70 % 1024 2619 2
50 % 2120 5401 1
40 % 2441 6098 1
30 % 2969 7565 1
Entity #2 | Chains: L
Fab light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 42393
95 % 35 99 230 Flexibility: Low
Max RMSD: 6.2, Avg RMSD: 1.8
PDBFlex
90 % 322 825 2
70 % 1032 2660 1
50 % 2121 5401 1
40 % 2442 6098 1
30 % 2970 7565 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
34 6EH4 2 E Human T Cell Receptor Beta Chain 9606
35 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
36 4BUH 1 A, B CLONE M0418 SCFV 9606
37 4B50 1 A 2H10 LLAMA VHH 9844
38 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
39 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
40 6FR4 1 A TCR 003 alpha chain 9606
41 6FR4 2 B TCR 003 Beta Chain 9606
42 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
43 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
44 6DBA 1 A, B nanobody VHH R303 9838
45 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
46 6EH5 2 B Human T Cell Receptor Beta Chain 9606
47 5YD4 1 A, C, E, G scFv 4B08 10090
48 5YD3 1 A, C, E, G scFv 4B08 10090
49 2XT1 2 B CAMELID VHH 9 30538
50 5UD9 1 H Fab heavy chain 9606
51 5UD9 2 L Light chain 9606
52 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
53 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
54 4P48 1 A Antibody scFv 180 9031
55 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
56 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
57 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
58 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
59 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
60 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
61 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
62 6FR3 1 A 003 TCR Alpha Chain 9606
63 6FR3 2 B 003 TCR Beta Chain 9606
64 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
65 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
66 5J1S 3 C VHH domain BS-2 30538
67 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
68 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
69 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
70 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
71 5L6Q 1 A, B H5AL 9606
72 5J1T 3 C VHH domain BS-2 30538
73 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
74 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
75 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
76 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
77 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
78 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
79 4XCF 1 L 4E10 Fab light chain 9606
80 4XCF 2 H 4E10 Fab heavy chain 9606
81 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
82 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
83 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
84 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
85 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
86 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
87 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
88 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
89 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
90 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
91 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
92 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
93 5X08 1 H Fab 4E10 Heavy chain 9606
94 5X08 2 L Fab 4E10 Light chain 9606
95 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
96 2X1O 1 A, B GELSOLIN NANOBODY 9844
97 4QGY 1 A, B nanobody n25, VH domain 9844
98 5C2B 1 H scFv 3B4 heavy chain 9606
99 5C2B 2 L 3B4 light chain 9606
100 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
101 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
102 4XAW 1 L 4E10 Fab light chain 9606
103 4XAW 2 H 4E10 Fab heavy chain 9606
104 5VNV 1 A Nb.b201 32630
105 4P49 1 A Antibody scFv B8 9031
106 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
107 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
108 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
109 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
110 5DXW 1 A PD-L1 nanobody 10090
111 2NW2 1 A ELS4 TCR alpha chain 9606
112 2NW2 2 B ELS4 TCR beta chain 9606
113 5UCB 1 H Fab Heavy Chain 9606
114 5UCB 2 L Fab Light Chain 9606
115 3T0W 1 A, B immunoglobulin variable lambda domain 9606
116 2VXV 1 H HUMAN IGG ABT-325 9606
117 2VXV 2 L HUMAN IGG ABT-325 9606
118 4N9O 2 B Nanobody Nb484 Nb484 9844
119 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
120 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
121 3T0V 1 A immunoglobulin variable lambda domain 9606
122 4GXV 1 H, I Antibody 1F1, heavy chain 9606
123 4GXV 2 L, M Antibody 1F1, light chain 9606
124 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
125 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
126 2VXT 1 H MURINE IGG 125-2H 10090
127 2VXT 3 L MURINE IGG 125-2H 10090
128 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
129 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
130 1T2J 1 A M12-Variable Heavy domain 9606
131 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
132 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
133 6DBF 2 B InlB specific VHH R303 9838
134 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
135 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
136 6DBG 2 C, D VHH R303 9838
137 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
138 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
139 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
140 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
141 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
142 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
143 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
144 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
145 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
146 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
147 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
148 5W24 1 L 5C4 Fab Light Chain 10090
149 5W24 2 H 5C4 Fab Heavy Chain 10090
150 4HPY 1 H CH59 Fab heavy chain 9606
151 4HPY 2 L CH59 Fab light chain 9606
152 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
153 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
154 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
155 5VM6 1 A single domain camelid nanobody VHH T10 9844
156 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
157 4JG1 1 L Fab light chain 9606
158 4JG1 2 H Fab heavy chain 9606
159 1SQ2 2 N novel antigen receptor 7801
160 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
161 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
162 4KML 2 B Nanobody 9844
163 5VF2 1 A scFv 2D10 10090
164 5I8C 1 A VRC34.01 Fab heavy chain 9606
165 5I8C 2 B VRC34.01 Fab light chain 9606
166 4O5L 1 L Fab F045-092 light chain 9606
167 4O5L 2 H Fab F045-092 heavy chain 9606
168 5MYX 1 A, C Fab c#24 light chain 10090
169 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
170 4Z9K 2 B VHH2(F5) antibody 30538
171 3IFL 1 L 12A11 FAB antibody light chain 10090
172 3IFL 2 H 12A11 FAB antibody heavy chain 10090
173 5WK2 1 L M116 LIGHT CHAIN 9606
174 5WK2 2 H M116 HEAVY CHAIN FD 9606
175 3PP4 1 H GA101 Fab heavy chain 10090
176 3PP4 2 L GA101 Fab light chain 10090
177 3KDM 1 A, L Immunoglobulin light chain 9606
178 3KDM 2 B, H Immunoglobulin heavy chain 9606
179 5NIV 1 A Light chain of 5D3 Fab 10090
180 5NIV 2 B Heavy chain of 5D3 Fab 10090
181 5N4J 1 L LIGHT CHAIN 9606
182 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
183 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
184 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
185 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
186 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
187 5X4G 1 A 6H8 Fab heavy chain 10090
188 5X4G 2 B 6H8 Fab light chain 10090
189 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
190 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
191 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
192 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
193 4PTU 1 A Antibody pn132p2C05, light chain 9606
194 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
195 4TPR 1 L If kappa light chain 10090
196 4TPR 2 H Fab heavy chain 10090
197 5LMW 1 A Nanobody 9844
198 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
199 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
200 3IFN 1 H 12A11 FAB antibody heavy chain 10090
201 3IFN 2 L 12A11 FAB antibody light chain 10090
202 5U3P 1 H DH511.4 Fab Heavy Chain 9606
203 5U3P 2 L DH511.4 Fab Light Chain 9606
204 6BLA 1 H AMM01 Fab Heavy chain 9606
205 6BLA 2 L AMM01 Fab Light chain 9606
206 5NM0 1 A, B, C, D Nb36 9844
207 4TOY 1 H 35O22 Fab Heavy chain 9606
208 4TOY 2 L 35O22 Fab Light chain 9606
209 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
210 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
211 3NPS 2 B S4 FAB HEAVY CHAIN 9606
212 3NPS 3 C S4 FAB LIGHT CHAIN 9606
213 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
214 5I4F 1 A scFv 2D10 10090
215 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
216 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
217 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
218 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
219 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
220 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
221 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
222 5WN9 1 H scFv 2D10 9606
223 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
224 4XC3 1 L 4E10 Fab light chain 9606
225 4XC3 2 H 4E10 Fab heavy chain 9606
226 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
227 4PPT 1 A Engineered single domain VHH antibody 9844
228 3R0M 1 A, B Llama VHH A12 9844
229 4M5Y 1 H, I Fab 5J8 heavy chain 9606
230 4M5Y 2 L, M Fab 5J8 light chain 9606
231 4TQE 1 L If kappa light chain 10090
232 4TQE 2 H Fab heavy chain 10090
233 3ZKQ 2 D XA4813 9844
234 5YY4 1 A scFv 4B08 10090
235 4I13 2 B Protein ca1697 (nanobody) 9844
236 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
237 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
238 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
239 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
240 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
241 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
242 5C2U 1 B Nanobody Nanobody 9838
243 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
244 5VSI 2 L CH1/Ckappa Fab light chain 9606
245 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
246 1XFP 1 A heavy chain antibody VHH domain 9838
247 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
248 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
249 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
250 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
251 5JXA 1 H VRC03 Heavy chain 9606
252 5JXA 2 L VRC03 Light chain 9606
253 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
254 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
255 4POY 1 A VHH-metal 9844
256 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
257 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
258 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
259 5NLW 1 A nanobody Nb36 9844
260 3CDC 1 A, B Light Chain Amyloidogenic 9606
261 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
262 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
263 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
264 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
265 3NTC 1 L Fab light chain 10090
266 3NTC 2 H Fab heavy chain 10090
267 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
268 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
269 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
270 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
271 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
272 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
273 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
274 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
275 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
276 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
277 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
278 6BE3 1 H Fab (F598) Heavy Chain 9606
279 6BE3 2 L Fab (F598) Light Chain 9606
280 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
281 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
282 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
283 3G9A 2 B Minimizer 9838
284 4NWU 1 H APE1551 Ab Fab heavy chain 9606
285 4NWU 2 L APE1551 Ab Fab light chain 9606
286 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
287 1KGC 1 D T-cell receptor alpha chain 9606
288 1KGC 2 E T-cell receptor beta chain 9606
289 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
290 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
291 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
292 6FRC 2 B Human T-Cell Receptor beta Chain 9606
293 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
294 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
295 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
296 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
297 5EWI 1 H VRC38.01 Heavy Chain 9606
298 5EWI 2 L VRC38.01 Light Chain 9606
299 5E2W 1 L AT8 LIGHT CHAIN 10090
300 5E2W 2 H AT8 HEAVY CHAIN 10090
301 5MYK 1 A Fab c#17 light chain 10090
302 5MYK 2 B Fab c#17 heavy chain 10090
303 6FUQ 1 A Human F11 T-Cell Receptor 9606
304 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
305 4NZR 1 H PGT135 heavy chain Fab 9606
306 4NZR 2 L PGT135 light chain Fab 9606
307 5MYO 1 A, C Fab c#6 light chain 10090
308 5MYO 2 B, D Fab c#6 heavy chain 10090
309 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
310 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
311 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
312 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
313 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
314 5UEL 1 H 354NC102 Fab Heavy Chain 9606
315 5UEL 2 L 354NC102 Fab Light Chain 9606
316 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
317 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
318 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
319 2P43 2 B ANTIBODY CAB-RN05 9838
320 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
321 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
322 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
323 5E2V 1 L AT8 LIGHT CHAIN 10090
324 5E2V 2 H AT8 HEAVY CHAIN 10090
325 4KRN 1 A Nanobody/VHH domain EgA1 9844
326 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
327 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
328 4GFT 2 B Nanobody 9844
329 4TVS 2 a, b VHH Domain BS-1 30538
330 4W6Y 2 B Nanobody NbFedF9 9844
331 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
332 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
333 6EZW 1 B VHH antibody BCD090-M2 9844
334 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
335 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
336 5JUE 1 L light chain of UIC2 Fab 10090
337 5JUE 2 H heavy chain of UIC2 Fab 10090
338 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
339 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
340 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
341 1UAC 2 H Ig VH,anti-lysozyme 10090
342 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
343 5JR1 1 H 10E8 heavy chain 9606
344 5JR1 2 L 10E8 mature light chain 9606
345 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
346 6CA7 1 L PCT64_13C light chain 9606
347 6CA7 2 H PCT64_13C heavy chain 9606
348 5VF6 1 A single chain variable fragment 9031
349 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
350 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
351 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
352 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
353 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
354 6FR9 2 B T-Cell Receptor F11 beta chain 9606
355 5OB5 2 H fAb Heavy chain 9606
356 5OB5 3 L fAb Light chain 9606
357 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
358 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
359 5I66 1 A 8B6 antibody, heavy chain 10090
360 5I66 2 B 8B6 antibody, light chain 10090
361 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
362 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
363 6BZY 1 H 22D11 Heavy Chain 10090
364 6BZY 2 L 22D11 Light Chain 10090
365 3QQ9 1 C, L 101F LIGHT CHAIN 10090
366 3QQ9 2 D, H 101F HEAVY CHAIN 10090
367 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
368 5TKK 3 L mouse antibody vFP5.01 light chain 10090
369 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
370 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
371 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
372 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
373 5W6C 1 H UCA Fab heavy chain 9606
374 5W6C 2 L UCA Fab light chain 9606
375 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
376 5I1K 1 L FAB LIGHT CHAIN 9606
377 5I1K 2 H FAB HEAVY CHAIN 9606
378 3OZ9 1 L Fab NC-1 kappa light chain 10090
379 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
380 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
381 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
382 5V7U 1 L CBTAU-22.1 Fab light chain 9606
383 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
384 5UEA 1 A, H Fab Heavy Chain 9606
385 5UEA 3 B, L Fab Light Chain 9606
386 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
387 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
388 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
389 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
390 3G5Y 1 A 175 light chain 10090
391 3G5Y 2 B 175 heavy chain 10090
392 5O02 2 C Nanobody (VHH) Nano-4 30538
393 5NMV 1 L Fab light chain 10088
394 5NMV 2 H Fab heavy chain 10088
395 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
396 4N8C 2 L, M Light chain of monoclonal antibody 10090
397 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
398 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
399 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
400 4HGW 1 A Antibody Fab fragment, light chain 10090
401 4HGW 2 B Antibody Fab fragment, heavy chain 10090
402 1NLB 1 L antibody 19D9D6 light chain 10090
403 1NLB 2 H antibody 19D9D6 heavy chain 10090
404 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
405 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
406 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
407 3VFG 1 L 3F8 Light Chain 10090
408 3VFG 2 H 3F8 Heavy Chain 10090
409 4X7F 2 C, D Nano-25 Nanobody 30538
410 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
411 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
412 3QRG 1 L Fab light chain 9606
413 3QRG 2 H Fab heavy chain Fd fragment 9606
414 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
415 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
416 5M6A 1 A, B, C, D Bence-Jones light chain 9606
417 4LLY 2 B, D light chain Clambda 9606
418 4LGR 2 B Camelid nanobody (VHH3) 30538
419 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
420 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
421 5EZI 1 H Fab c12 heavy chain 9606
422 5EZI 2 L Fab c12 Light chain 9606
423 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
424 4K23 1 H anti-uPAR antibody, heavy chain 10090
425 4K23 2 L anti-uPAR antibody, light chain 10090
426 5J57 2 B VHH single chain antibody V5E1 30538
427 3NCJ 1 L Fab15 Mut8 light chain 9606
428 3NCJ 2 H Fab15 Mut8 heavy chain 9606
429 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
430 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
431 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
432 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
433 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
434 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
435 5W05 1 L M59 FAB LIGHT CHAIN 10090
436 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
437 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
438 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
439 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
440 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
441 5OMM 2 C Nanobody (VHH) Nano-14 30538
442 5E03 1 A mouse CTLA-4 nanobody 10090
443 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
444 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
445 4M61 1 A, C Fab A52 light chain 10090
446 4M61 2 B, D Fab A52 heavy chain 10090
447 5YE3 1 B 2A7D9 VH CH1 chain 10090
448 5YE3 2 A 2A7D9 L chain 10090
449 5LZ0 1 A, B PorM nanobody 9844
450 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
451 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
452 1UM5 1 L Antibody 21H3 L chain 10090
453 1UM5 2 H Antibody 21H3 H chain 10090
454 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
455 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
456 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
457 4NWT 1 L APE1531 Ab Fab light chain 9606
458 4NWT 2 H APE1531 Ab Fab heavy chain 9606
459 6DBE 1 A, B nanobody VHH R303 9844
460 3WHX 1 A mAb Fab H fragment 10090
461 3WHX 2 B mAb Fab L fragment 10090
462 3NA9 1 L Fab15 light chain 9606
463 3NA9 2 H Fab15 heavy chain 9606
464 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
465 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
466 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
467 6FUO 2 B Human F11 T-Cell Receptor 9606
468 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
469 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
470 4LRI 1 A, B MSL-109 Light Chain 9606
471 4LRI 2 C, P MSL-109 Heavy Chain 9606
472 2XXC 1 B CAMELID VHH 9 30538
473 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
474 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
475 4JN2 1 A, L anti dabigatran Fab 10090
476 4JN2 2 B, H anti dabigatran Fab 10090
477 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
478 4XBE 2 H 4E10 Fab heavy chain 9606
479 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
480 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
481 6BE2 1 H Fab (F598) Heavy Chain 9606
482 6BE2 2 L Fab (F598) Light Chain 9606
483 3QYC 1 A, B VH domain of IgG molecule 9606
484 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
485 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
486 4JFZ 1 L Fab light chain 9606
487 4JFZ 2 H Fab heavy chain 9606
488 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
489 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
490 5VAK 2 B Nb914 Nanobody 9844
491 3WIF 1 A mAb Fab H fragment 10090
492 3WIF 2 B mAb Fab L fragment 10090
493 5U6A 1 A Light Chain 9606
494 5U6A 2 B Heavy Chain 9606
495 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
496 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
497 3MBX 1 L X836 LIGHT CHAIN 10090
498 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
499 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
500 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
501 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
502 2XXM 2 B CAMELID VHH 9 30538
503 6APC 1 H Epididymis luminal protein 214 9606
504 6APC 2 L IGL@ protein 9606
505 6BJ8 3 D TCR 55 alpha chain 9606
506 6BJ8 4 H TCR 55 beta chain 9606
507 5IR3 1 A Ig lambda chain V-VI region AR 9606
508 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
509 4HHA 1 A Fab KE5 Fab fragment KE5 9606
510 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
511 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
512 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
513 4RGO 2 H 14G8 heavy chain Fab 10090
514 4RGO 3 L 14G8 light chain Fab 10090
515 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
516 5GRY 1 A, G diabody 9606
517 5UEK 2 H Fab 12E Heavy Chain 9606
518 5UEK 3 L Fab 12E Light Chain 9606
519 3NAA 1 L Fab15 Mut5 light chain 9606
520 3NAA 2 H Fab15 Mut5 heavy chain 9606
521 6DBD 1 A, B, C, D nanobody VHH R326 9844
522 1Q0X 1 L Fab 9B1, light chain 10090
523 1Q0X 2 H Fab 9B1, heavy chain 10090
524 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
525 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
526 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
527 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
528 5JDS 1 B Nanobody 9835
529 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
530 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
531 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
532 5IK3 2 B, D 1E03 Fab fragment light chain 9606
533 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
534 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
535 5XLI 1 a, b FabL 10090
536 5XLI 2 c, d FabH 10090
537 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
538 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
539 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
540 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
541 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
542 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
543 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
544 4WUK 1 H CH65 heavy chain 9606
545 4WUK 2 L CH65 light chain 9606
546 5L8L 2 B New antigen receptor variable domain 168098
547 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
548 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
549 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
550 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
551 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
552 5JOP 1 D, L Fab 14.22 light chain 10090
553 5JOP 2 E, H Fab14.22 heavy chain 10090
554 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
555 4HPO 1 H CH58 Fab heavy chain 9606
556 4HPO 2 L CH58 Fab light chain 9606
557 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
558 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
559 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
560 5UKN 2 L DH522UCA Fab fragment light chain 9544
561 4AIZ 1 A, C, D V2-17 PROTEIN 9606
562 4AIZ 2 B V2-17 PROTEIN 9606
563 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
564 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
565 5L21 2 B VHH-C2 30538
566 5IT2 1 H heavy chain 9606
567 5IT2 2 L light chain 9606
568 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
569 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
570 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
571 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
572 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
573 2W59 1 A, B IGY FCU3-4 9031
574 5FWO 1 A NANOBODY 9844
575 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
576 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
577 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
578 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
579 4L1H 1 A Ig kappa chain V-I region Rei 9606
580 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
581 5MO3 3 L Fab of monoclonal antibody, light chain 10090
582 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
583 5GZ0 1 A, C FM329 light chain 1383439
584 5GZ0 2 B, D FM329 heavy chain 1383439
585 6DW2 1 A 6078 Fab light chain 9606
586 6DW2 2 B 6078 Fab heavy chain 9606
587 3B9V 1 A, B, C, D heavy chain variable domain 9606
588 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
589 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
590 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
591 6BQB 1 L MGG4 Fab light chain 9606
592 6BQB 2 H MGG4 Fab heavy chain 9606
593 4PUB 1 H DX-2930 HEAVY CHAIN 9606
594 4PUB 2 L DX-2930 LIGHT CHAIN 9606
595 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
596 6B14 2 L Light chain of Fab BL3-6S97N 10090
597 5N88 1 A, H VH59 antibody 9606
598 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
599 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
600 5TEZ 4 I TCR F50 alpha chain 9606
601 5TEZ 5 J TCR F50 beta chain 9606
602 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
603 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
604 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
605 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
606 5GS3 1 A, H diabody protein 9606
607 3BD3 1 A, B catalytic antibody 10090
608 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
609 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
610 2OTU 1 A, C, E, G Fv light chain variable domain 10090
611 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
612 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
613 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
614 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
615 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
616 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
617 5VKD 2 H Fab Heavy Chain 9606
618 5VKD 3 L Fab light chain 9606
619 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
620 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
621 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
622 5XHG 1 A, C polypeptide(L) 10090
623 5XHG 2 B, D polypeptide(H) 10090
624 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
625 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
626 5L8J 2 B New antigen receptor variable domain 168098
627 3UYR 1 H antibody Fab heavy chain 10090
628 3UYR 2 L antibody Fab light chain 10090
629 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
630 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
631 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
632 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
633 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
634 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
635 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
636 3OAZ 2 K, L Fab 2G12, light chain 9606
637 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
638 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
639 1T6V 2 N, O novel antigen receptor 7801
640 1ZAN 1 L Fab AD11 Light Chain 10116
641 1ZAN 2 H Fab AD11 Heavy Chain 10116
642 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
643 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
644 6CJK 1 A, C Immunoglobulin Fab light chain 9986
645 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
646 4N0Y 1 H IGH526 Heavy Chain 9606
647 4N0Y 2 L IGH526 Light Chain 9606
648 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
649 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
650 5MTH 1 A, H antibody Fab heavy chain 10090
651 5MTH 2 B, L antibody Fab light chain 10090
652 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
653 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
654 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
655 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
656 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
657 1RZF 1 L Fab E51 light chain 9606
658 1RZF 2 H Fab E51 heavy chain 9606
659 4N1C 1 A, B immunoglobulin variable light chain domain 9606
660 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
661 4KTE 2 L GE148 Light Chain Fab 9544
662 5I8O 1 H HMM5 antibody heavy chain 9606
663 5I8O 2 L HMM5 antibody light chain 9606
664 4OUO 1 A anti Bla g 1 scFv 9031
665 4JG0 1 L Fab light chain 9606
666 4JG0 2 H Fab heavy chain 9606
667 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
668 4YGV 2 B, L aDabi-Fab2a light chain 9606
669 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
670 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
671 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
672 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
673 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
674 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
675 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
676 3EO0 1 A, C GC-1008 Fab Light Chain 10090
677 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
678 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
679 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
680 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
681 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
682 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
683 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
684 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
685 6FUR 2 B, D Human F11 T-Cell Receptor 9606
686 4POU 2 B VHH Antibody 9844
687 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
688 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
689 4FQI 3 H antibody CR9114 heavy chain Fab 9606
690 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
691 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
692 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
693 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
694 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
695 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
696 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
697 4JHA 2 L D25 light chain 9606
698 6B9Z 1 A Trastuzumab Fab light chain 10090
699 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
700 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
701 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
702 4PTT 1 A Antibody pn132p2C05, light chain 9606
703 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
704 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
705 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
706 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
707 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
708 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
709 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
710 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
711 2P42 2 B, D ANTIBODY CAB-RN05 9838
712 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
713 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
714 6CPH 1 D TCR alpha chain 9606
715 6CPH 2 E TCR beta chain 9606
716 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
717 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
718 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
719 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
720 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
721 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
722 4DGV 1 H HCV1 Heavy Chain Fab 9606
723 4DGV 2 L HCV1 Light Chain 9606
724 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
725 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
726 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
727 5TH2 1 A, C cetuximab Fab, light chain 10090
728 5TH2 2 B, D cetuximab Fab, heavy chain 10090
729 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
730 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
731 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
732 5I8K 1 L HHH1 Fab Light chain 9606
733 5I8K 2 H HHH1 Fab Heavy chain 9606
734 4QLR 1 A, B Llama nanobody n02 VH domain 9844
735 5J56 2 B VHH single chain antibody V1C7 30538
736 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
737 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
738 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
739 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
740 1YNL 1 L Ig gamma light chain 10090
741 1YNL 2 H Ig gamma heavy chain 10090
742 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
743 5EPM 2 B, F Antibody Fab fragment light chain 10090
744 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
745 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
746 5VH5 1 A Infliximab Fc 10090
747 3UMT 1 A scFv heavy chain and light chain 10090
748 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
749 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
750 4NUJ 1 A PGT152 light chain 9606
751 4NUJ 2 B PGT152 heavy chain 9606
752 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
753 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
754 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
755 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
756 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
757 3U2S 2 B, L PG9 light chain 9606
758 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
759 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
760 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
761 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
762 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
763 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
764 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
765 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
766 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
767 4NUG 1 L PGT151 light chain 9606
768 4NUG 2 H PGT151 heavy chain 9606
769 3IU4 1 H chP3 Fab heavy chain 10090
770 3IU4 2 L chP3 Fab light chain 10090
771 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
772 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
773 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
774 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
775 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
776 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
777 1P7K 1 A, L antibody light chain FAB 10090
778 1P7K 2 B, H antibody heavy chain FAB 10090
779 4NBX 2 B A20.1 VHH 9844
780 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
781 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
782 3RVV 2 C 4C1 - light chain 10090
783 3RVV 3 D 4C1 - heavy chain 10090
784 4HEP 2 G vHH17 domain 9844
785 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
786 3P0Y 2 H Fab DL11 heavy chain 9606
787 3P0Y 3 L Fab DL11 light chain 9606
788 4NPY 1 A, L germline PGT121 light chain Fab 9606
789 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
790 6ANA 2 H LL2 Fab Heavy Chain 10090
791 6ANA 3 L LL2 Fab Light Chain 10090
792 5IBU 1 B, L 6652 Light Chain 9606
793 5IBU 2 G, H 6652 Heavy Chain 9606
794 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
795 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
796 5VPL 2 C 4C1 - LIGHT CHAIN 10090
797 5VPL 3 D 4C1 - HEAVY CHAIN 10090
798 6AOD 1 A FXIa Antibody FAB Light Chain 9606
799 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
800 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
801 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
802 2YPV 2 H FAB 12C1 10090
803 2YPV 3 L FAB 12C1 10090
804 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
805 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
806 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
807 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
808 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
809 4JY5 1 L PGT122 light chain Fab 9606
810 4JY5 2 H PGT122 heavy chain Fab 9606
811 6ELE 1 A, H fAB heavy chain 9606
812 6ELE 2 B, L fAB light chain 9606
813 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
814 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
815 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
816 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
817 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
818 6B5R 1 H CIS42 Fab Heavy chain 9606
819 6B5R 2 L CIS42 Fab Light chain 9606
820 5IML 2 B Nanobody 9835
821 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
822 3NAC 1 L Fab15 Mut7 light chain 9606
823 3NAC 2 H Fab15 Mut7 heavy chain 9606
824 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
825 3A6C 2 H IG VH, anti-lysozyme 10090
826 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
827 2DQD 2 H Ig VH,anti-lysozyme 10090
828 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
829 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
830 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
831 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
832 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
833 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
834 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
835 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
836 1Q72 1 L Fab M82G2, Light chain 10090
837 1Q72 2 H Fab M82G2, Heavy chain 10090
838 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
839 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
840 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
841 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
842 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
843 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
844 4YHO 1 H aDabi-Fab3 heavy chain 9606
845 4YHO 2 L aDabi-Fab3 light chain 9606
846 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
847 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
848 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
849 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
850 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
851 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
852 4DGY 1 H HCV1 Heavy Chain Fab 9606
853 4DGY 2 L HCV1 Light Chain 9606
854 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
855 3A67 2 H IG VH, anti-lysozyme 10090
856 2APB 1 A T-cell receptor beta chain V 10116
857 2APX 1 A T cell receptor beta chain V 10116
858 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
859 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
860 6EH6 2 B Human T Cell Receptor BetaChain 9606
861 5EN2 1 A GD01 heavy chain 10090
862 5EN2 2 B GD01 light chain 10090
863 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
864 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
865 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
866 1J1X 2 H Ig VH,anti-lysozyme 10090
867 5L8K 2 B New antigen receptor variable domain 168098
868 5M2J 2 D Anti-(ED-B) scFV 9606
869 3MXW 2 L 5E1 light chain 9606
870 3MXW 3 H 5E1 heavy chain 9606
871 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
872 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
873 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
874 2DQC 2 H Ig VH,anti-lysozyme 10090
875 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
876 1J1O 2 H Ig VH,anti-lysozyme 10090
877 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
878 3EO9 1 L Efalizumab Fab fragment, light chain 9606
879 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
880 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
881 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
882 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
883 4M62 2 H, I GEP2 FV heavy chain 9606
884 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
885 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
886 5IVO 1 A BC2-nanobody 30538
887 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
888 1J1P 2 H Ig VH,anti-lysozyme 10090
889 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
890 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
891 4NBZ 2 B, D A26.8 VHH 9844
892 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
893 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
894 5WUV 1 L light chain 9606
895 5WUV 2 H heavy chain 9606
896 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
897 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
898 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
899 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
900 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
901 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
902 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
903 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
904 5AYU 2 H Ig VH,anti-lysozyme 10090
905 4JM4 1 H PGT 135 Heavy Chain Fab 9606
906 4JM4 2 L PGT 135 Light Chain Fab 9606
907 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
908 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
909 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
910 3A6B 2 H IG VH, anti-lysozyme 10090
911 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
912 2DQJ 2 H Ig VH,anti-lysozyme 10090
913 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
914 5YE4 2 B, D 1A9D7 L chain 10090
915 5F21 2 B nanobody MU375 9844
916 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
917 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
918 6B0G 1 C 1245 Antibody, Light Chain 9606
919 6B0G 2 D 1245 Antibody, Heavy Chain 9606
920 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
921 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
922 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
923 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
924 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
925 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
926 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
927 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
928 6D0X 1 A 2140 Antibody, heavy chain 9606
929 6D0X 2 B 1210 Antibody, light chain 9606
930 2Q86 1 A, C Valpha14 TCR extracellular domain 10090
931 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
932 2P44 2 B ANTIBODY CAB-RN05 9838
933 6BE4 1 H Fab (F598) Heavy Chain 9606
934 6BE4 2 L Fab(F598) Light Chain 9606
935 6FRB 1 A Human T-Cell Receptor F11 alpha chain 9606
936 6FRB 2